3 results
Approved WMORecruiting
To determine the objective response rate of entrectinib, as assessed by BICR, in each patient population basket of solid tumors that harbor anNTRK1/2/3, ROS1, or ALK gene rearrangement
Approved WMOCompleted
Primary Objective:To assess the efficacy potential of GSK3196165 on pain in inflammatory HOA.Secondary endpoints:To evaluate impact of GSK3196165 on average and worst HOA pain, over time.To assess the impact of GSK3196165 on hand pain (on use),…
Approved WMOPending
To assess the sensitivity and specificity of optical spectroscopy for the detection of Invasive Ductal Carcinoma (IDC) and Ductal Carcinoma In Situ (DCIS) deposits on resection margins during breast conserving surgery.